Harrison's Practice

Abdominal Aortic Aneurysm

Definition

  • A pathologic dilatation of a segment of the abdominal aorta
    • Aortic wall diameter > 3 cm or 50% greater than the uninvolved proximal vessel
  • Classification
    • True aneurysm
      • Involves all 3 layers of the vessel wall
    • Pseudoaneurysm
      • Intimal and medial layers of the vessel wall are disrupted.
      • Dilatation is lined by adventitia only and sometimes by perivascular clot.
    • Fusiform aneurysm
      • Affects entire circumference of a segment of the vessel
      • Makes a diffusely dilated lesion
    • Saccular aneurysm
      • Involves only a portion of the circumference
      • Results in outpouching of the vessel wall

Epidemiology

  • Incidence
    • ~40,000 persons undergo aneurysmorrhaphy annually in the U.S.
    • ~15,000 deaths in the U.S. are attributed to abdominal aortic aneurysm (AAA).
  • Prevalence
    • Rupture of AAA causes 1.3% of deaths in men 65–85 years of age.
  • Sex
    • Occurs more frequently in men than women
  • Age
    • Incidence increases with age.
  • Race
    • More common in white men than black men
    • Prevalence in white and black women is similar.

Risk Factors

  • Existing atherosclerosis in other blood vessels
  • Affected first-degree relatives
  • Peripheral artery aneurysms
  • Cigarette smoking
  • Hypertension

Etiology

  • Exact etiology is unknown but is probably multifactorial.
    • Genetics, biomechanics, and atherosclerosis are contributors.
  • Results from conditions that cause degradation or abnormal production of the aortic wall’s structural components, elastin and collagen.
  • Causes of aortic aneurysms may be broadly categorized as:
    • Degenerative diseases
      • Factors associated with degenerative aortic aneurysms include aging, cigarette smoking, hypercholesterolemia, male sex, and a family history of aortic aneurysms.
      • The most common pathologic condition associated with degenerative aortic aneurysms is atherosclerosis.
        • It is controversial whether atherosclerosis itself causes AAA or whether atherosclerosis develops as a secondary event in the dilated aorta.
    • Inherited or developmental diseases
    • Infections
      • Mycotic aneurysms (Salmonella, staphylococcal, streptococcal, fungal)
    • Vasculitis
      • Behçet’s disease (causes thoracic and abdominal aortic aneurysms)
    • Trauma

Associated Conditions

Symptoms & Signs

  • AAA commonly produces no symptoms.
  • Usually detected on routine examination as a palpable, pulsatile, and nontender mass, or as an incidental finding during abdominal radiography or ultrasonography.
  • As AAAs expand, they may cause discomfort.
    • Strong pulsations in the abdomen
    • Pain in the chest, lower back, or scrotum
    • Recent onset of aneurysmal pain is usually a harbinger of rupture and represents a surgical emergency.
  • More often, acute rupture occurs without prior warning; this complication is always life threatening and requires emergency surgery.
    • Acute pain and hypotension occur with rupture of the aneurysm.
    • May present as syncope
  • Rarely, there is leakage of the aneurysm, with severe pain and tenderness.

Differential Diagnosis

Diagnostic Approach

  • AAA is commonly found as incidental finding on physical examination or imaging study.
  • Once identified, work-up should focus on need for surgery.
  • In a patient presenting with AAA and acute abdominal or back pain, rupture should be presumed and surgical evaluation undertaken immediately.

Laboratory Tests

  • Patients presenting with a ruptured AAA may have:
    • Anemia due to retroperitoneal bleeding
    • Acidosis
  • In mycotic aneurysms, blood cultures are often positive and reveal the nature of the infecting agent.

Imaging

  • Abdominal ultrasonography
    • Can delineate transverse and longitudinal dimensions of AAA and may detect mural thrombus
    • Useful for serial documentation of aneurysm size
    • Can be used to screen patients at risk for AAA
    • Study of choice for rapid bedside diagnosis in patients presenting with suspected or actual rupture of AAA
  • CT with contrast, MRI (See Figure 1.)
    • Accurate, noninvasive tests to determine the location and size of AAA
    • Not practical in patients who present with acute rupture of AAA
  • Contrast aortography (See Figure 2.)
    • Used for evaluation of aneurysms before elective surgery
    • Carries a small risk of complications, such as bleeding, allergic reactions, atheroembolism and nephrotoxicity, especially in patients with baseline renal dysfunction
    • Useful in documenting length of the aneurysm, especially upper and lower limits, and the extent of associated atherosclerotic vascular disease
    • Presence of mural clots may reduce the luminal size; thus, aortography may underestimate the diameter of an aneurysm.
  • Abdominal radiography
    • May demonstrate calcified outline of the aneurysm.
    • ~25% of aneurysms are not calcified and cannot be visualized by plain radiography.
    • Usually an incidental finding, and not used for diagnosis

Diagnostic Procedures

  • Not indicated

Treatment Approach

  • Operative repair of the aneurysm is indicated for AAAs of any size that are expanding rapidly or are associated with symptoms.
  • Unstable patients who present with rupture should have standard resuscitative measures (e.g., intravenous access, cardiac monitoring, supplemental oxygen) while preparing for transfer to the operating room.
  • For asymptomatic AAA, surgery is indicated if the diameter is > 5.5 cm.
  • Operative repair for AAA 5–5.5 cm is controversial.

Specific Treatments

Surgery

  • All patients with symptomatic AAA require urgent or emergent surgery.
  • Asymptomatic patients with AAA > 5.5 cm in diameter should undergo repair.
  • In surgical candidates, careful preoperative cardiac and general medical evaluations are essential.
    • Follow with appropriate therapy for complicating conditions.
      • Preexisting coronary artery disease
      • Congestive heart failure
      • Pulmonary disease
      • Diabetes
      • Advanced age
  • β-adrenergic blockers decrease perioperative cardiovascular morbidity and mortality.
  • Perioperative management should include placement of a Swan–Ganz catheter and arterial line to monitor and optimize:
    • Left ventricular filling pressure
    • Cardiac output
    • Arterial pressure, especially during clamping and unclamping of the aorta and in the immediate postoperative period
  • Percutaneous placement of endovascular stent grafts for treatment of infrarenal AAA is available for selected patients.
    • Lower short-term morbidity compared with open surgical reconstruction
    • Comparable long-term mortality compared with open surgical reconstruction
    • Becoming an increasingly common technique for ruptured AAA
      • Currently associated with a mortality rate of approximately 40%
      • Lower mortality compared with open repair may reflect selected patient population.

Monitoring

  • Asymptomatic AAA < 5 cm should be followed by ultrasonography, CT, or MRI every 3 months if diameter is 4.5–5.5 cm and every 6 months if diameter is < 4.5 cm.

Complications

  • Rupture is the most important and life-threatening complication of AAA.
    • Mortality rate approaches 50%.
    • Risk of rupture increases with the size of the AAA.
  • Formation of mural thrombi within the aneurysm may predispose to peripheral embolization.

Prognosis

  • Prognosis is related to both the size of the aneurysm and the severity of coexisting coronary artery and cerebrovascular disease.
  • The risk of rupture increases with the size of the aneurysm.
    • Annual risk of rupture
      • < 4 cm: 0.3%
      • 4–4.9 cm: 1.5%
      • 5–5.9 cm: 6.5%
      • >6 cm: Risk increases sharply.
  • Operative mortality rate for elective surgery approximates 1–2%.
  • After acute rupture, the operative mortality rate approximates 45–50%.

Prevention

  • Ultrasonographic screening in patients at risk may be helpful.
    • In 1 larger study, ultrasonographic screening of men 65–74 years of age was associated with a risk reduction in aneurysm-related death by 42%.
    • According to the Cochrane Database Review: [1]
      • There is evidence of a significant reduction in mortality from AAA in men aged 65–79 years who undergo ultrasound screening.
      • There is insufficient evidence to demonstrate benefit in women.

ICD-9-CM

  • 441.4 Abdominal (aortic) aneurysm without mention of rupture
  • 441.3 Abdominal aneurysm, ruptured

See Also

Internet Sites

References

  1. Cosford PA, Leng GC: Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev , 2007  [PMID:17443519]

General Bibliography

  • Ashton HA et al: The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360:1531, 2002  [PMID:12443589]
  • Baril DT, Jacobs TS, Marin ML: Surgery insight: advances in endovascular repair of abdominal aortic aneurysms. Nat Clin Pract Cardiovasc Med 4:206, 2007  [PMID:17380166]
  • Blanchard JF, Armenian HK, Friesen PP: Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 151:575, 2000  [PMID:10733039]
  • Blankensteijn JD et al: Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 352:2398, 2005  [PMID:15944424]
  • Fleming C et al: Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 142:203, 2005  [PMID:15684209]
  • Greco G et al: Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg 43:453, 2006  [PMID:16520154]
  • Isselbacher EM et al: Diseases of the aorta, in Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed, DP Zipes et al (eds). Philadelphia, Saunders, 2005
  • Isselbacher EM: Thoracic and abdominal aortic aneurysms. Circulation 111:816, 2005  [PMID:15710776]
  • Kim LG et al: A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 146:699, 2007  [PMID:17502630]
  • Lederle FA et al: Systematic review: repair of unruptured abdominal aortic aneurysm. Ann Intern Med 146:735, 2007  [PMID:17502634]
  • Lederle FA et al: Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346:1437, 2002  [PMID:12000813]
  • Powell JT, Greenhalgh RM: Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 348:1895, 2003  [PMID:12736283]
  • Sakalihasan N, Limet R, Defawe OD: Abdominal aortic aneurysm. Lancet 365:1577, 2005 Apr 30-May 6  [PMID:15866312]
  • Towne JB: Endovascular treatment of abdominal aortic aneurysms. Am J Surg 189:140, 2005  [PMID:15720980]
  • United Kingdom Small Aneurysm Trial Participants: Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346:1445, 2002  [PMID:12000814]
  • This topic is based on Harrison’s Principles of Internal Medicine, 17th edition, chapter 242, Diseases of the Aorta by MA Creager and J Loscalzo.

Abdominal Aortic Aneurysm is a sample topic found in
Harrison's Practice.

To find other Harrison's Practice topics
please login or purchase a subscription.

Content Manager
Related Content
Diseases of the Aorta

more ...